MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 194 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $263,000 | +40.6% | 10,000 | 0.0% | 0.04% | +32.1% |
Q4 2020 | $187,000 | +10.0% | 10,000 | 0.0% | 0.03% | -3.4% |
Q3 2020 | $170,000 | -27.0% | 10,000 | 0.0% | 0.03% | -29.3% |
Q2 2020 | $233,000 | +177.4% | 10,000 | 0.0% | 0.04% | +141.2% |
Q1 2020 | $84,000 | -14.3% | 10,000 | 0.0% | 0.02% | +6.2% |
Q4 2019 | $98,000 | +3.2% | 10,000 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $95,000 | -20.2% | 10,000 | 0.0% | 0.02% | -20.0% |
Q2 2019 | $119,000 | -32.4% | 10,000 | 0.0% | 0.02% | -33.3% |
Q1 2019 | $176,000 | +1.1% | 10,000 | 0.0% | 0.03% | -9.1% |
Q4 2018 | $174,000 | +16.8% | 10,000 | 0.0% | 0.03% | +32.0% |
Q3 2018 | $149,000 | -6.3% | 10,000 | 0.0% | 0.02% | -10.7% |
Q2 2018 | $159,000 | +12.0% | 10,000 | 0.0% | 0.03% | +12.0% |
Q1 2018 | $142,000 | +1.4% | 10,000 | 0.0% | 0.02% | +8.7% |
Q4 2017 | $140,000 | -2.1% | 10,000 | 0.0% | 0.02% | -4.2% |
Q3 2017 | $143,000 | -9.5% | 10,000 | 0.0% | 0.02% | -7.7% |
Q2 2017 | $158,000 | +14.5% | 10,000 | 0.0% | 0.03% | +13.0% |
Q1 2017 | $138,000 | – | 10,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |